EP4161548A4 - Extraction of psychoactive compounds from psychedelic fungus - Google Patents

Extraction of psychoactive compounds from psychedelic fungus Download PDF

Info

Publication number
EP4161548A4
EP4161548A4 EP21827107.0A EP21827107A EP4161548A4 EP 4161548 A4 EP4161548 A4 EP 4161548A4 EP 21827107 A EP21827107 A EP 21827107A EP 4161548 A4 EP4161548 A4 EP 4161548A4
Authority
EP
European Patent Office
Prior art keywords
psychedelic
fungus
extraction
psychoactive compounds
psychoactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21827107.0A
Other languages
German (de)
French (fr)
Other versions
EP4161548A1 (en
Inventor
Benjamin Lightburn
Ryan Moss
Lisa Ranken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psilo Scientific Ltd
Original Assignee
Psilo Scientific Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psilo Scientific Ltd filed Critical Psilo Scientific Ltd
Priority to EP24165048.0A priority Critical patent/EP4372094A2/en
Priority to EP24152237.4A priority patent/EP4339200A3/en
Publication of EP4161548A1 publication Critical patent/EP4161548A1/en
Publication of EP4161548A4 publication Critical patent/EP4161548A4/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids
    • B01D11/0215Solid material in other stationary receptacles
    • B01D11/0253Fluidised bed of solid materials
    • B01D11/0257Fluidised bed of solid materials using mixing mechanisms, e.g. stirrers, jets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids
    • B01D11/028Flow sheets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids
    • B01D11/0288Applications, solvents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP21827107.0A 2020-06-17 2021-06-16 Extraction of psychoactive compounds from psychedelic fungus Pending EP4161548A4 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP24165048.0A EP4372094A2 (en) 2020-06-17 2021-06-16 Aqueous extraction of psychoactive compounds from psilocybin fungus
EP24152237.4A EP4339200A3 (en) 2020-06-17 2021-06-16 Ethanol extraction of psychoactive compounds from psilocybin fungus

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063040317P 2020-06-17 2020-06-17
US202063046089P 2020-06-30 2020-06-30
CA3088384A CA3088384C (en) 2020-06-17 2020-07-29 Extraction of psychoactive compounds from psilocybin fungus
CA3089455A CA3089455C (en) 2020-06-17 2020-08-07 Methanol-based extraction of psychoactive compounds from fungus
PCT/CA2021/050822 WO2021253123A1 (en) 2020-06-17 2021-06-16 Extraction of psychoactive compounds from psychedelic fungus

Related Child Applications (3)

Application Number Title Priority Date Filing Date
EP24152237.4A Division EP4339200A3 (en) 2020-06-17 2021-06-16 Ethanol extraction of psychoactive compounds from psilocybin fungus
EP24152237.4A Division-Into EP4339200A3 (en) 2020-06-17 2021-06-16 Ethanol extraction of psychoactive compounds from psilocybin fungus
EP24165048.0A Division EP4372094A2 (en) 2020-06-17 2021-06-16 Aqueous extraction of psychoactive compounds from psilocybin fungus

Publications (2)

Publication Number Publication Date
EP4161548A1 EP4161548A1 (en) 2023-04-12
EP4161548A4 true EP4161548A4 (en) 2024-04-24

Family

ID=72895839

Family Applications (3)

Application Number Title Priority Date Filing Date
EP24165048.0A Pending EP4372094A2 (en) 2020-06-17 2021-06-16 Aqueous extraction of psychoactive compounds from psilocybin fungus
EP24152237.4A Pending EP4339200A3 (en) 2020-06-17 2021-06-16 Ethanol extraction of psychoactive compounds from psilocybin fungus
EP21827107.0A Pending EP4161548A4 (en) 2020-06-17 2021-06-16 Extraction of psychoactive compounds from psychedelic fungus

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP24165048.0A Pending EP4372094A2 (en) 2020-06-17 2021-06-16 Aqueous extraction of psychoactive compounds from psilocybin fungus
EP24152237.4A Pending EP4339200A3 (en) 2020-06-17 2021-06-16 Ethanol extraction of psychoactive compounds from psilocybin fungus

Country Status (6)

Country Link
EP (3) EP4372094A2 (en)
AU (1) AU2021291583B2 (en)
BR (1) BR112022025777A2 (en)
CA (6) CA3088384C (en)
MX (1) MX2022016531A (en)
WO (2) WO2021253123A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3152752A1 (en) 2019-10-01 2021-04-08 Thomas Henley Genetic engineering of fungi to modulate tryptamine expression
EP4153564A4 (en) 2020-05-19 2024-06-19 Cybin IRL Limited Deuterated tryptamine derivatives and methods of use
BR112022025780A2 (en) 2020-06-17 2023-01-10 Psilo Scientific Ltd METHOD FOR GENERATING A PSYCHOACTIVE ALKALOID EXTRACT, METHOD FOR GENERATING A PSYCHOACTIVE PHOSPHORYLATED ALKALOID EXTRACT, AND METHOD FOR GENERATING A DEPHOSPHORYLATED PSYCHOACTIVE ALKALOID EXTRACT
MX2023004350A (en) * 2020-10-23 2023-09-12 Psilo Scientific Ltd Process for obtaining a purified psychoactive alkaloid solution.
CA3197443A1 (en) * 2020-12-28 2022-06-28 Psilo Scientific Ltd. Processes for extracting psychoactive alkaloids and preparation thereof into transmucosal forms
CA3127180C (en) * 2021-08-06 2024-03-05 Psilo Scientific Ltd. Pre-evaporation standardization of extracted psychoactive compounds
CA3232767A1 (en) * 2021-09-17 2023-03-23 1242753 Ontario Inc. Psilocybin derived compositions and methods of using same
CA3232692A1 (en) * 2021-09-28 2023-04-06 Joseph Girardi Chilled juice extraction processes and products using psychedelic and functional mushrooms
CA3133547A1 (en) * 2021-10-07 2023-04-07 Psilo Scientific Ltd. Liquid-liquid extraction of purified psychoactive alkaloid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB911946A (en) * 1958-02-21 1962-12-05 Sandoz Ltd Psilocybin and psilocin and processes for their preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU36879A1 (en) 1958-02-21
CN101292727A (en) * 2008-05-30 2008-10-29 曹晋忠 Powder preparing method for mushroom ethyl alcohol extract
GB2571696B (en) * 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2019099745A1 (en) * 2017-11-16 2019-05-23 CaaMTech, LLC Compositions comprising a psilocybin derivative and a cannabinoid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB911946A (en) * 1958-02-21 1962-12-05 Sandoz Ltd Psilocybin and psilocin and processes for their preparation

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JANIS FRICKE ET AL: "Production Options for Psilocybin: Making of the Magic", CHEMISTRY - A EUROPEAN JOURNAL, vol. 25, no. 4, 18 January 2019 (2019-01-18), DE, pages 897 - 903, XP055766088, ISSN: 0947-6539, DOI: 10.1002/chem.201802758 *
PELLEGRINI MANUELA ET AL: "Magic truffles or Philosopher's stones: a legal way to sell psilocybin?", vol. 5, no. 3, 28 February 2013 (2013-02-28), pages 182 - 185, XP009547892, ISSN: 1942-7611, Retrieved from the Internet <URL:https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdta.1400> [retrieved on 20120809], DOI: 10.1002/DTA.1400 *
PIOTR PAWEL WIECZOREK ET AL: "Bioactive Alkaloids of Hallucinogenic Mushrooms", 30 November 2015 (2015-11-30), XP009545779, ISBN: 978-0-444-63462-7, Retrieved from the Internet <URL:https://ebookcentral.proquest.com/lib/epo-ebooks/reader.action?docID=2036175&ppg=148> [retrieved on 20150427] *
PSILOCYBIN EXERT: "Formulating New 'Magic Mushroom' compositions", INTERNET CITATION, 13 February 2018 (2018-02-13), pages 1 - 7, XP009542154, Retrieved from the Internet <URL:https://web.archive.org/web/20200704105500/https://psilocybintechnology.com/formulating-new-magic-mushroom-compositions/> [retrieved on 20230305] *
See also references of WO2021253123A1 *
TSUJIKAWA KENJI ET AL: "Morphological and chemical analysis of magic mushrooms in Japan", vol. 138, no. 1-3, 30 November 2003 (2003-11-30), pages 85 - 90, XP009547895, ISSN: 0379-0738, Retrieved from the Internet <URL:https://api.elsevier.com/content/article/PII:S0379073803003785?httpAccept=text/plain> [retrieved on 20230919], DOI: 10.1016/J.FORSCIINT.2003.08.009 *

Also Published As

Publication number Publication date
EP4339200A2 (en) 2024-03-20
CA3124367A1 (en) 2020-10-07
MX2022016531A (en) 2023-09-12
EP4372094A2 (en) 2024-05-22
EP4339200A3 (en) 2024-03-27
AU2021291583A1 (en) 2023-02-02
CA3198238A1 (en) 2021-12-23
CA3089455A1 (en) 2021-09-14
AU2021291583B2 (en) 2023-12-07
CA3161623C (en) 2023-04-04
WO2021253124A1 (en) 2021-12-23
CA3161623A1 (en) 2021-12-23
CA3123908A1 (en) 2020-10-07
CA3088384A1 (en) 2020-10-07
CA3088384C (en) 2021-08-03
CA3089455C (en) 2022-07-05
CA3123908C (en) 2022-03-22
WO2021253123A1 (en) 2021-12-23
EP4161548A1 (en) 2023-04-12
BR112022025777A2 (en) 2023-01-10
CA3124367C (en) 2022-04-26

Similar Documents

Publication Publication Date Title
EP4161548A4 (en) Extraction of psychoactive compounds from psychedelic fungus
NZ600845A (en) Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
IL288938B (en) Methods for extraction, processing and purification of a selected family of target compounds from cannabis
EP3417853A4 (en) Pharmaceutical composition for treatment of cancer, containing polyphenol compound as active ingredient
EP4098258A4 (en) Pharmaceutical use of ketoamide-based compound
EP3843580A4 (en) Method for design of insoles
EP4190774A4 (en) Solid form of compound
EP4155294A4 (en) Compound for preventing or treating lipid metabolism-related diseases
EP4099999A4 (en) Formulations of docetaxel
EP4121403A4 (en) Nitro-aminoadamantane compounds for the treatment of betacoronavirus infections
EP4161547A4 (en) Methanol-based extraction of psychoactive compounds from fungus
GB202200753D0 (en) Pharmaceutical compounds
EP4144731A4 (en) Compounds containing benzosultam
EP4132441A4 (en) Blood extraction
WO2012097371A3 (en) Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
EP4097504A4 (en) Frequency information rapid extraction for ranging applications
EP3986413A4 (en) Polymorphs of a macrocyclic kinase inhibitor
AU2021903633A0 (en) Extraction of products from cannabis
BR112017016393A2 (en) stable pharmaceutical compositions comprising antibacterial agent
AU2020901996A0 (en) Method of extraction
AU2023903109A0 (en) Anticancer compounds
AU2021900342A0 (en) Formulations for improved bioavailability of fenretinide
AU2022902781A0 (en) Anticancer compounds
GB202007208D0 (en) Separation of e.g virions debris into particular types of debris v4
EP4101469A4 (en) Use of polyether compound

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230106

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSILO SCIENTIFIC LTD

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240326

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 17/10 20060101ALI20240320BHEP

Ipc: A61P 25/00 20060101ALI20240320BHEP

Ipc: A61K 45/06 20060101ALI20240320BHEP

Ipc: C12P 17/00 20060101ALI20240320BHEP

Ipc: C07F 9/572 20060101ALI20240320BHEP

Ipc: C07D 209/16 20060101ALI20240320BHEP

Ipc: B01D 11/02 20060101ALI20240320BHEP

Ipc: A61K 31/675 20060101ALI20240320BHEP

Ipc: A61K 31/4045 20060101ALI20240320BHEP

Ipc: A23L 31/00 20160101ALI20240320BHEP

Ipc: A61K 36/07 20060101AFI20240320BHEP